|
1) Winter JN, Weller EA, Horning SJ, et al. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood. 2006; 107: 4207-13
|
|
|
|
2) Schwickert TA, Lindquist RL, Shakhar G, et al. In vivo imaging of germinal centres reveals a dynamic open structure. Nature. 2007; 446: 83-7
|
|
|
|
|
|
3) Allen CD, Okada T, Tang HL, et al. Imaging of germinal center selection events during affinity maturation. Science. 2007; 315: 528-31
|
|
|
|
|
|
4) Hauser AE, Junt T, Mempel TR, et al. Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity. 2007; 26: 655-67
|
|
|
|
|
|
5) Fukuda T, Yoshida T, Okada S, et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med. 1997; 186: 439-48
|
|
|
|
|
|
6) Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet. 1997; 16: 161-70
|
|
|
|
|
|
7) Dent AL, Shaffer AL, Yu X, et al. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 1997; 276: 589-92
|
|
|
|
|
|
8) Tunyaplin C, Shaffer AL, Angelin-Duclos CD, et al. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol. 2004; 173: 1158-65
|
|
|
|
|
|
9) Scheeren FA, Naspetti M, Diehl S, et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol. 2005; 6: 303-13
|
|
|
|
|
|
10) Toyama H, Okada S, Hatano M, et al. Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. Immunity. 2002; 17: 329-39
|
|
|
|
|
|
11) Kuo TC, Shaffer AL, Haddad J, et al. Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med. 2007; 204: 819-30
|
|
|
|
|
|
12) Walker SR, Nelson EA, Frank DA. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene. 2007; 26: 224-33
|
|
|
|
|
|
13) Parekh S, Polo JM, Shaknovich R, et al. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood. 2007; 110: 2067-74
|
|
|
|
|
|
14) Mendez LM, Polo JM, Yu JJ, et al. CtBP is an essential corepressor for BCL6 autoregulation. Mol Cell Biol. 2008; 28: 2175-86
|
|
|
|
|
|
15) Chevallier N, Corcoran CM, Lennon C, et al. ETO protein of t(8; 21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood. 2004; 103: 1454-63
|
|
|
|
|
|
16) Phan RT, Saito M, Basso K, et al. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol. 2005; 6: 1054-60
|
|
|
|
|
|
17) Polo JM, Juszczynski P, Monti S, et al. Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas. Proc Natl Acad Sci U S A. 2007; 104: 3207-12
|
|
|
|
|
|
18) Arima M, Fukuda T, Tokuhisa T. Role of the transcriptional repressor BCL6 in allergic response and inflammation. WAO Journal. 2008; 1: 115-22
|
|
|
|
|
|
19) Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature. 2004; 432: 635-9
|
|
|
|
|
|
20) Polo JM, Dell'Oso T, Ranuncolo SM, et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med. 2004; 10: 1329-35
|
|
|
|
|
|
21) Ranuncolo SM, Polo JM, Dierov J, et al. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol. 2007; 8: 705-14
|
|
|
|
|
|
22) Ranuncolo SM, Polo JM, Melnick A. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. Blood Cells Mol Dis. 2008; 41: 95-9
|
|
|
|
|
|
23) Nakamura Y, Saito K, Furusawa S. Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma. Br J Haematol. 1999; 105: 274-7
|
|
|
|
|
|
24) Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001; 412: 341-6
|
|
|
|
|
|
25) Pasqualucci L, Migliazza A, Basso K, et al. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood. 2003; 101: 2914-23
|
|
|
|
|
|
26) Bereshchenko OR, Gu W, Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nat Genet. 2002; 32: 606-13
|
|
|
|
|
|
27) Fujita N, Jaye DL, Geigerman C, et al. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell. 2004; 119: 75-86
|
|
|
|
|
|
28) Kurosu T, Fukuda T, Miki T, et al. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene. 2003; 22: 4459-68
|
|
|
|
|
|
29) Phan RT, Saito M, Kitagawa Y, et al. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. Nat Immunol. 2007; 8: 1132-9
|
|
|
|
|
|
30) Klein U, Casola S, Cattoretti G, et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol. 2006; 7: 773-82
|
|
|
|
|
|
31) Teng Y, Takahashi Y, Yamada M, et al. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Eur J Cell Biol. 2007; 86: 581-9
|
|
|
|
|
|
32) Saito M, Gao J, Basso K, et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell. 2007; 12: 280-92
|
|
|
|
|
|
33) Polo JM, Ci W, Licht JD, et al. Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells. Blood. 2008; 112: 644-51
|
|
|
|
|
|
34) Cattoretti G, Pasqualucci L, Ballon G, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell. 2005; 7: 445-55
|
|
|
|
|
|
35) Muramatsu M, Kinoshita K, Fagarasan S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102: 553-63
|
|
|
|
|
|
36) Suematsu S, Matsusaka T, Matsuda T, et al. Generation of plasmacytomas with the chromosomal translocation t(12; 15) in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A. 1992; 89: 232-5
|
|
|
|
|
|
37) Ramiro AR, Jankovic M, Eisenreich T, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell. 2004; 118: 431-8
|
|
|
|
|
|
38) Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet. 2008; 40: 108-12
|
|
|
|
|